Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Samsung Biologics (207940 KS)
Watchlist
303
Analysis
Health Care
•
South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Alteogen Inc
•
10 Feb 2023 17:16
Alteogen (196170 KS): Distinct Platform Technology; Biosimilar Pipeline; Potential Value Unlocking
Alteogen’s formulation platform change technology is in constant demand. The company can be potential first-mover in Eylea biosimilar. Its...
Tina Banerjee
Follow
432 Views
Share
bullish
•
Mankind Pharma
•
09 Feb 2023 10:55
Mankind Pharma Pre-IPO - Thoughts on Valuations
Mankind Pharma is looking to raise about US$1bn in its upcoming India IPO. In this note, we will talk about valuations.
Sumeet Singh
Follow
372 Views
Share
bullish
•
Syngene International Ltd
•
08 Feb 2023 19:47
Syngene International Ltd (SYNG IN): Well-Positioned to Capitalize On Strong Industry Tailwind
Through capacity and capability addition in biologics manufacturing and expansion of commercial API manufacturing, Syngene has expanded...
Tina Banerjee
Follow
355 Views
Share
bullish
•
Samsung Biologics
•
31 Jan 2023 23:20
Samsung Biologics (207940 KS): 2022 Revenue Surpassed KRW3T; Strong Growth Momentum to Continue
Samsung Biologics reported record high consolidated annual revenue in 2022 and became the first and only Korean pharma company to surpass KRW3T...
Tina Banerjee
Follow
304 Views
Share
bullish
•
Samsung C&T
•
26 Jan 2023 07:59
Korean Holdcos Vs Opcos Gap Spreads Opportunities in 1Q 2023
In this insight, we highlight the pricing gap divergences of the major Korean holdcos and opcos in 1Q 2023. We highlight 33 pair trades that...
Douglas Kim
Follow
367 Views
Share
First
Previous
11
12
13
14
15
16
17
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x